ROLE OF BUCCAL FAT PAD DERIVED STROMAL VASCULAR FRACTION(SVF) IN THE TREATMENT OF GUMS DISEASE

CLINICAL AND RADIOGRAPHICAL EVALUATION OF BUCCAL FAT PAD DERIVED STROMAL VASCULAR FRACTION(SVF) IN THE TREATMENT OF GRADE II FURCATION DEFECTS

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/09/036161

Enrollment

Registered

2021-09-02

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Buccal fat pad derived stromal vascular fraction: 10 sites will be treated with bone graft(DFDBA) and GTR(CM) and buccal fat pad derived stromal vascular fraction(BFPSVF) Control Interv

Eligibility

Inclusion criteria

Inclusion criteria: patient willing to participate for the entire duration of the study and readily available for periodic follow up patient with good oral hygiene minimum 20 permanent teeth should be present furcation defect of 2-4mm

Exclusion criteria

Exclusion criteria: patient with uncontrolled metabolic diseases, compromised immmune system, pregnancy and prior radiation therapy of surgical site patient with history of alcoholism, drug abuse and excessive smoking

Design outcomes

Primary

Measure	Time frame
furcation defects will decreaseTimepoint: baseline ,3 months, 6 months	—

Secondary

Measure	Time frame
osseous defects will reduceTimepoint: baseline, 3 months, 6 months	—

Countries

India

Contacts

Public ContactSyed samiuzzama

kamineni institute of dental sciences

syed75620@gmail.com7975998235

Outcome results